Market by Type (Expanded Polytetrafluoroethylene (ePTFE), Polyurethane, Polyethylene Terephthalate (PET), Other Types) Blood Vessel Diameter (Large , Medium, Small) Patient Demographic (Adult, Pediatric) Application (Aortic Disease, Peripheral Artery, Hemodialysis) End-User (Hospital, Specialty Clinics, Ambulatory Surgical Center, Other End-User) and Country Outlook | Forecast 2024-2032
As per Triton’s research, the Latin America artificial blood vessels market is estimated to grow in terms of revenue at a CAGR of 6.19% during the forecast years 2024-2032.
​​Report scope can be customized per your requirements - Request Free Sample Report
The artificial blood vessels market in Latin America is gaining traction, driven by advancements in medical technology and increasing cases of cardiovascular diseases. Governments in the region, particularly in countries like Brazil and Mexico, have started prioritizing healthcare improvements, focusing on expanding access to cutting-edge treatments such as artificial blood vessels. Brazil has made significant strides, investing in healthcare infrastructure and research to address cardiovascular issues, which are expected to create lucrative opportunities for the artificial blood vessels market.Â
The countries analyzed in this region include:
Brazil leads the region’s market, accounting for $54.84 million in 2023
The Brazilian government introduced the National Development Strategy for the Health Economic-Industrial Complex in September 2023. This initiative, aimed at strengthening local production and technology adoption, includes support for innovative biomedical technologies like artificial blood vessels.Â
The CEIS program encourages partnerships between public institutions and private entities to stimulate innovation in health technologies. These partnerships, referred to as Productive Development Partnerships (PDPs), focus on promoting the local production of critical health technologies.Â
As part of its broader strategy, Brazil is looking to expand its infrastructure for the development of cutting-edge medical solutions, including technologies like artificial blood vessels.
Market Forecast for Mexico
The artificial blood vessels market in Mexico is influenced by the country’s broader healthcare initiatives, especially in cardiovascular care. Cardiovascular diseases are a significant concern, with numerous efforts underway to address gaps in diagnosis and treatment. Mexico has partnered with international organizations, such as the American Heart Association, to improve the consistency of care for conditions like atherosclerosis and heart failure. This partnership focuses on standardizing treatment protocols and implementing quality improvement strategies across healthcare facilities.
​The market is segmented into type, patient demographic, blood vessel diameter, application, and end-user. The application section includes peripheral artery, aortic disease, and hemodialysis.Â
Peripheral artery applications involve using grafts to treat conditions that affect blood flow to the legs, arms, and other peripheral areas of the body. A key reason for using these grafts is peripheral artery disease (PAD), where arteries become narrowed or blocked due to plaque buildup (atherosclerosis). In severe cases, artificial grafts are employed in bypass surgeries to redirect blood around the blocked artery, ensuring proper circulation to the affected limb.
Contender Analysis in the Artificial Blood Vessels Market:
Becton, Dickinson and Company (BD) is a global leader in medical technology, specializing in the design, manufacture, and distribution of medical devices, laboratory equipment, and diagnostic tools. Headquartered in New Jersey, BD provides essential products to healthcare providers and institutions worldwide, supporting patient care and advancing medical research across various fields.
Other major firms in this market are Medtronic Plc, Getinge AB, Roumai Medical, and WL Gore and Associates Inc.Â
KEY DELIVERABLES OF THE REPORT:
Market CAGR during the forecasting years 2024-2032
Detailed data highlighting key insights, industry components, and market strategies
Comprehensive information and estimation of the artificial blood vessels market revenue growth in Latin America and its influence on the parent market
In-depth study of forthcoming trends in consumer behavioral patterns
A meticulous analysis of the competitive landscape and Porter’s Five Forces
A wide-ranging study of factors that will challenge the LA artificial blood vessels market’s growth during the upcoming years
Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET
– SUMMARY
2. INDUSTRY OUTLOOK
2.1. PORTER’S FIVE FORCES ANALYSIS
2.1.1. THREAT OF NEW ENTRANTS
2.1.2. THREAT OF SUBSTITUTES
2.1.3. BARGAINING POWER OF BUYERS
2.1.4. BARGAINING POWER OF SUPPLIERS
2.1.5. THREAT OF COMPETITIVE RIVALRY
2.2. MARKET MATURITY ANALYSIS
2.3. SUPPLY CHAIN ANALYSIS
2.3.1. RAW MATERIALS
2.3.2. MANUFACTURERS
2.3.3. DISTRIBUTORS
2.3.4. END-USER
2.4. REGULATORY FRAMEWORK
2.5. KEY BUYING IMPACT ANALYSIS
2.5.1. BIOCOMPATIBILITY
2.5.2. DURABILITY AND LONGEVITY
2.5.3. CUSTOMIZATION AND VERSATILITY
2.5.4. REGULATORY COMPLIANCE AND QUALITY ASSURANCE
2.6. KEY MARKET STRATEGIES
2.6.1. COLLABORATIONS
2.6.2. PRODUCT LAUNCHES
2.6.3. ACQUISITIONS
2.6.4. BUSINESS DIVESTITURES & EXPANSIONS
2.7. MARKET DRIVERS
2.7.1. RISING RATES OF CARDIOVASCULAR DISEASES AND
VASCULAR DISORDERS
2.7.2. DEVELOPMENTS IN TISSUE ENGINEERING AND
REGENERATIVE MEDICINE
2.7.3. AGING POPULATION AND SHIFTING LIFESTYLES
2.8. MARKET CHALLENGES
2.8.1. EXPENSES IN THE DEVELOPMENT AND
COMMERCIALIZATION OF ARTIFICIAL BLOOD VESSELS
2.8.2. STRICT REGULATORY APPROVALS AND CLINICAL
TRIAL REQUIREMENTS
2.8.3. CHALLENGES RELATED TO BIOCOMPATIBILITY AND
LONG-TERM DURABILITY
2.9. MARKET OPPORTUNITIES
2.9.1. ADVANCEMENTS IN 3D BIOPRINTING FOR TAILORED
VASCULAR GRAFTS
2.9.2. USE OF NANOTECHNOLOGY AND BIOMIMETIC
MATERIALS TO ENHANCE FUNCTIONALITY
2.10. ANALYST PERSPECTIVE
3. LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET
– BY TYPE
3.1. EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE)
3.2. POLYETHYLENE TEREPHTHALATE (PET)
3.3. POLYURETHANE
3.4. OTHER TYPES
4. LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET
– BY BLOOD VESSEL DIAMETER
4.1. LARGE
4.2. MEDIUM
4.3. SMALL
5. LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET
– BY PATIENT DEMOGRAPHIC
5.1. PEDIATRIC
5.2. ADULT
6. LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET
– BY APPLICATION
6.1. PERIPHERAL ARTERY
6.2. HEMODIALYSIS
6.3. AORTIC DISEASE
7. LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET
– BY END-USER
7.1. HOSPITAL
7.2. SPECIALTY CLINIC
7.3. AMBULATORY SURGICAL CENTER
7.4. OTHER END-USERS
8. LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET
– BY COUNTRY OUTLOOK
8.1. LATIN AMERICA
8.1.1. BRAZIL
8.1.1.1. BRAZIL ARTIFICIAL BLOOD
VESSELS MARKET FORECAST & PROSPECTS
8.1.2. MEXICO
8.1.2.1. MEXICO ARTIFICIAL BLOOD
VESSELS MARKET FORECAST & PROSPECTS
8.1.3. REST OF LATIN AMERICA
8.1.3.1. REST OF LATIN AMERICA ARTIFICIAL
BLOOD VESSELS MARKET FORECAST & PROSPECTS
9. COMPETITIVE LANDSCAPE
9.1. BECTON, DICKINSON AND COMPANY
9.1.1. OVERVIEW
9.1.2. PORTFOLIO
9.1.3. KEY STRENGTHS
9.1.4. KEY CHALLENGE
9.2. LEMAITRE VASCULAR INC
9.2.1. OVERVIEW
9.2.2. PORTFOLIO
9.2.3. KEY STRENGTHS
9.2.4. KEY CHALLENGE
9.3. MEDTRONIC PLC
9.3.1. OVERVIEW
9.3.2. PORTFOLIO
9.3.3. KEY STRENGTH
9.3.4. KEY CHALLENGE
9.4. TERUMO MEDICAL CORPORATION
9.4.1. OVERVIEW
9.4.2. PORTFOLIO
9.4.3. KEY STRENGTHS
9.4.4. KEY CHALLENGE
9.5. W. L. GORE AND ASSOCIATES INC
9.5.1. OVERVIEW
9.5.2. PORTFOLIO
9.5.3. KEY STRENGTHS
9.5.4. KEY CHALLENGES
9.6. GETINGE AB
9.6.1. OVERVIEW
9.6.2. PORTFOLIO
9.6.3. KEY STRENGTHS
9.6.4. KEY CHALLENGE
9.7. ROUMAI MEDICAL
9.7.1. OVERVIEW
9.7.2. PORTFOLIO
9.7.3. KEY STRENGTHS
9.7.4. KEY CHALLENGES
9.8. MEDICALEXPO
9.8.1. OVERVIEW
9.8.2. PORTFOLIO
9.8.3. KEY STRENGTHS
9.8.4. KEY CHALLENGES
9.9. VASCULAR GRAFT SOLUTIONS
9.9.1. OVERVIEW
9.9.2. PORTFOLIO
9.9.3. KEY STRENGTHS
9.9.4. KEY CHALLENGES
9.10. JIANGSU BIODA LIFE SCIENCE CO LTD
9.10.1. OVERVIEW
9.10.2. PORTFOLIO
9.10.3. KEY STRENGTHS
9.10.4. KEY CHALLENGE
10. RESEARCH METHODOLOGY & SCOPE
10.1. RESEARCH SCOPE & DELIVERABLES
10.2. SOURCES OF DATA
10.3. RESEARCH METHODOLOGY
TABLE 1: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY COUNTRY
OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF COLLABORATIONS
TABLE 4: LIST OF PRODUCT LAUNCHES
TABLE 5: LIST OF ACQUISITIONS
TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 7: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY TYPE,
2024-2032 (IN $ MILLION)
TABLE 8: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY BLOOD VESSEL
DIAMETER, 2024-2032 (IN $ MILLION)
TABLE 9: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY PATIENT
DEMOGRAPHIC, 2024-2032 (IN $ MILLION)
TABLE 10: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY APPLICATION,
2024-2032 (IN $ MILLION)
TABLE 11: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY END-USER,
2024-2032 (IN $ MILLION)
TABLE 12: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY COUNTRY
OUTLOOK, 2024-2032 (IN $ MILLION)
FIGURE 1: MARKET MATURITY ANALYSIS
FIGURE 2: SUPPLY CHAIN ANALYSIS
FIGURE 3: KEY BUYING IMPACT ANALYSIS
FIGURE 4: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY TYPE, 2023
& 2032 (IN %)
FIGURE 5: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY EXPANDED
POLYTETRAFLUOROETHYLENE (EPTFE), 2024-2032 (IN $ MILLION)
FIGURE 6: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY POLYETHYLENE
TEREPHTHALATE (PET), 2024-2032 (IN $ MILLION)
FIGURE 7: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY POLYURETHANE,
2024-2032 (IN $ MILLION)
FIGURE 8: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY OTHER TYPES,
2024-2032 (IN $ MILLION)
FIGURE 9: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY BLOOD VESSEL
DIAMETER, 2023 & 2032 (IN %)
FIGURE 10: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY LARGE,
2024-2032 (IN $ MILLION)
FIGURE 11: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY MEDIUM,
2024-2032 (IN $ MILLION)
FIGURE 12: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY SMALL,
2024-2032 (IN $ MILLION)
FIGURE 13: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY PATIENT
DEMOGRAPHIC, 2023 & 2032 (IN %)
FIGURE 14: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY PEDIATRIC,
2024-2032 (IN $ MILLION)
FIGURE 15: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY ADULT,
2024-2032 (IN $ MILLION)
FIGURE 16: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY APPLICATION,
2023 & 2032 (IN %)
FIGURE 17: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY PERIPHERAL
ARTERY, 2024-2032 (IN $ MILLION)
FIGURE 18: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY
HEMODIALYSIS, 2024-2032 (IN $ MILLION)
FIGURE 19: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY AORTIC
DISEASE, 2024-2032 (IN $ MILLION)
FIGURE 20: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY END-USER,
2023 & 2032 (IN %)
FIGURE 21: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY HOSPITAL,
2024-2032 (IN $ MILLION)
FIGURE 22: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY SPECIALTY
CLINIC, 2024-2032 (IN $ MILLION)
FIGURE 23: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY ONLINE
PHARMACY, 2024-2032 (IN $ MILLION)
FIGURE 24: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY OTHER
END-USERS, 2024-2032 (IN $ MILLION)
FIGURE 25: LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY COUNTRY
OUTLOOK, 2023 & 2032 (IN %)
FIGURE 26: BRAZIL ARTIFICIAL BLOOD VESSELS MARKET 2024-2032 (IN $
MILLION)
FIGURE 27: MEXICO ARTIFICIAL BLOOD VESSELS MARKET 2024-2032 (IN $
MILLION)
FIGURE 28: REST OF LATIN AMERICA ARTIFICIAL BLOOD VESSELS MARKET
2024-2032 (IN $ MILLION)